Coupe N, Schadendorf D, Danson S, et al. PACMEL: A randomised phase 2 study of paclitaxel with or without trametinib or pazopanib in Advanced BRAF wild type melanoma. SMR 2017, abstract SMR05-2.
Circulerend tumor-DNA als biomarker bij pancreascarcinoom
sep 2019 | Maag-darm-leveroncologie